{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:23:51Z","timestamp":1785381831071,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014718","name":"innovative research group project of the national natural science foundation of china","doi-asserted-by":"publisher","award":["21877081"],"award-info":[{"award-number":["21877081"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"innovative research group project of the national natural science foundation of china","doi-asserted-by":"publisher","award":["31771407"],"award-info":[{"award-number":["31771407"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Guangdong Provincial Key S&T Program","award":["2018B030336001"],"award-info":[{"award-number":["2018B030336001"]}]},{"name":"the Shenzhen Science and Technology Innovation Commission","award":["JCYJ20200109110001818"],"award-info":[{"award-number":["JCYJ20200109110001818"]}]},{"name":"the Investigation and evaluation of neural mechanisms associated with development of language, emotion, and cognitive disorders","award":["2021SHIBS0003"],"award-info":[{"award-number":["2021SHIBS0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12011-021-02938-1","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T06:16:24Z","timestamp":1642227384000},"page":"3248-3264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer\u2019s Disease in Triple-Transgenic Middle-Aged Mice"],"prefix":"10.1007","volume":"200","author":[{"given":"Zhijun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazuan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"4","key":"2938_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMe1714638","volume":"378","author":"MP Murphy","year":"2018","unstructured":"Murphy MP (2018) Amyloid-beta solubility in the treatment of Alzheimer\u2019s disease. N Engl J Med 378(4):391\u2013392. https:\/\/doi.org\/10.1056\/NEJMe1714638","journal-title":"N Engl J Med"},{"issue":"4","key":"2938_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M et al (2018) Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med 378(4):321\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1705971","journal-title":"N Engl J Med"},{"key":"2938_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2017.07.006","volume":"297","author":"N Jin","year":"2017","unstructured":"Jin N, Zhu H, Liang X, Huang W, Xie Q, Xiao P et al (2017) Sodium selenate activated Wnt\/beta-catenin signaling and repressed amyloid-beta formation in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Neurol 297:36\u201349. https:\/\/doi.org\/10.1016\/j.expneurol.2017.07.006","journal-title":"Exp Neurol"},{"issue":"11","key":"2938_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 6(11):1054\u20131061. https:\/\/doi.org\/10.1038\/ncb1104-1054","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2938_CR5","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82(12):4245\u20134249. https:\/\/doi.org\/10.1073\/pnas.82.12.4245","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2938_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awx347","volume":"141","author":"TE Cope","year":"2018","unstructured":"Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K et al (2018) Tau burden and the functional connectome in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain 141(2):550\u2013567. https:\/\/doi.org\/10.1093\/brain\/awx347","journal-title":"Brain"},{"issue":"2","key":"2938_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, Polanco JC, Ittner LM, Gotz J (2015) Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol 129(2):207\u2013220. https:\/\/doi.org\/10.1007\/s00401-014-1371-2","journal-title":"Acta Neuropathol"},{"issue":"9","key":"2938_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672. https:\/\/doi.org\/10.1038\/nrn2194","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2938_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11427-018-9350-1","volume":"62","author":"Y Dong","year":"2019","unstructured":"Dong Y, Stewart T, Zhang Y, Shi M, Tan C, Li X et al (2019) Anti-diabetic vanadyl complexes reduced Alzheimer\u2019s disease pathology independent of amyloid plaque deposition. Sci China Life Sci 62(1):126\u2013139. https:\/\/doi.org\/10.1007\/s11427-018-9350-1","journal-title":"Sci China Life Sci"},{"key":"2938_CR10","doi-asserted-by":"publisher","first-page":"22769","DOI":"10.1038\/srep22769","volume":"6","author":"G Paglia","year":"2016","unstructured":"Paglia G, Miedico O, Cristofano A, Vitale M, Angiolillo A, Chiaravalle AE et al (2016) Distinctive pattern of serum elements during the progression of Alzheimer\u2019s disease. Sci Rep 6:22769. https:\/\/doi.org\/10.1038\/srep22769","journal-title":"Sci Rep"},{"issue":"2","key":"2938_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1039\/c3mt00301a","volume":"6","author":"R Gonzalez-Dominguez","year":"2014","unstructured":"Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL (2014) Characterization of metal profiles in serum during the progression of Alzheimer\u2019s disease. Metallomics 6(2):292\u2013300. https:\/\/doi.org\/10.1039\/c3mt00301a","journal-title":"Metallomics"},{"issue":"6","key":"2938_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000129365","volume":"25","author":"L Gerhardsson","year":"2008","unstructured":"Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 25(6):508\u2013515. https:\/\/doi.org\/10.1159\/000129365","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"2938_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/toxsci\/kfv325","volume":"150","author":"ST Szabo","year":"2016","unstructured":"Szabo ST, Harry GJ, Hayden KM, Szabo DT, Birnbaum L (2016) Comparison of metal levels between postmortem brain and ventricular fluid in Alzheimer\u2019s disease and nondemented elderly controls. Toxicol Sci 150(2):292\u2013300. https:\/\/doi.org\/10.1093\/toxsci\/kfv325","journal-title":"Toxicol Sci"},{"issue":"3","key":"2938_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/0394632017719601","volume":"30","author":"AMA Adam","year":"2017","unstructured":"Adam AMA, Naglah AM, Al-Omar MA, Refat MS (2017) Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations. Int J Immunopathol Pharmacol 30(3):272\u2013281. https:\/\/doi.org\/10.1177\/0394632017719601","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"8","key":"2938_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2174\/1568026615666150827094652","volume":"16","author":"X Niu","year":"2016","unstructured":"Niu X, Xiao R, Wang N, Wang Z, Zhang Y, Xia Q et al (2016) The molecular mechanisms and rational design of anti-diabetic vanadium compounds. Curr Top Med Chem 16(8):811\u2013822. https:\/\/doi.org\/10.2174\/1568026615666150827094652","journal-title":"Curr Top Med Chem"},{"key":"2938_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinorgbio.2017.04.023","volume":"173","author":"D Sanna","year":"2017","unstructured":"Sanna D, Ugone V, Serra M, Garribba E (2017) Speciation of potential anti-diabetic vanadium complexes in real serum samples. J Inorg Biochem 173:52\u201365. https:\/\/doi.org\/10.1016\/j.jinorgbio.2017.04.023","journal-title":"J Inorg Biochem"},{"issue":"12","key":"2938_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jinorgbio.2006.08.016","volume":"100","author":"KH Thompson","year":"2006","unstructured":"Thompson KH, Orvig C (2006) Vanadium in diabetes: 100 years from phase 0 to phase I. J Inorg Biochem 100(12):1925\u20131935. https:\/\/doi.org\/10.1016\/j.jinorgbio.2006.08.016","journal-title":"J Inorg Biochem"},{"issue":"5","key":"2938_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00775-011-0780-0","volume":"16","author":"Z Gao","year":"2011","unstructured":"Gao Z, Zhang C, Yu S, Yang X, Wang K (2011) Vanadyl bisacetylacetonate protects beta cells from palmitate-induced cell death through the unfolded protein response pathway. J Biol Inorg Chem 16(5):789\u2013798. https:\/\/doi.org\/10.1007\/s00775-011-0780-0","journal-title":"J Biol Inorg Chem"},{"issue":"7","key":"2938_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1039\/c3mt20249f","volume":"5","author":"P Zhao","year":"2013","unstructured":"Zhao P, Yang X (2013) Vanadium compounds modulate PPARgamma activity primarily by increasing PPARgamma protein levels in mouse insulinoma NIT-1 cells. Metallomics 5(7):836\u2013843. https:\/\/doi.org\/10.1039\/c3mt20249f","journal-title":"Metallomics"},{"issue":"6","key":"2938_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00775-013-1007-3","volume":"18","author":"Y Wu","year":"2013","unstructured":"Wu Y, Huang M, Zhao P, Yang X (2013) Vanadyl acetylacetonate upregulates PPARgamma and adiponectin expression in differentiated rat adipocytes. J Biol Inorg Chem 18(6):623\u2013631. https:\/\/doi.org\/10.1007\/s00775-013-1007-3","journal-title":"J Biol Inorg Chem"},{"key":"2938_CR21","doi-asserted-by":"publisher","unstructured":"Irving E, Stoker AW (2017) Vanadium Compounds as PTP Inhibitors. Molecules 22(12) https:\/\/doi.org\/10.3390\/molecules22122269.","DOI":"10.3390\/molecules22122269"},{"issue":"3","key":"2938_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jinorgbio.2009.12.001","volume":"104","author":"CC McLauchlan","year":"2010","unstructured":"McLauchlan CC, Hooker JD, Jones MA, Dymon Z, Backhus EA, Greiner BA et al (2010) Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes. J Inorg Biochem 104(3):274\u2013281. https:\/\/doi.org\/10.1016\/j.jinorgbio.2009.12.001","journal-title":"J Inorg Biochem"},{"key":"2938_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1478-811x-11-96","volume":"11","author":"RV Rajala","year":"2013","unstructured":"Rajala RV, Basavarajappa DK, Dighe R, Rajala A (2013) Spatial and temporal aspects and the interplay of Grb14 and protein tyrosine phosphatase-1B on the insulin receptor phosphorylation. Cell Commun Signal 11:96. https:\/\/doi.org\/10.1186\/1478-811x-11-96","journal-title":"Cell Commun Signal"},{"issue":"4","key":"2938_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1039\/c9mt00271e","volume":"12","author":"Z He","year":"2020","unstructured":"He Z, Han S, Wu C, Liu L, Zhu H, Liu A et al (2020) Bis(ethylmaltolato)oxidovanadium(iv) inhibited the pathogenesis of Alzheimer\u2019s disease in triple transgenic model mice. Metallomics 12(4):474\u2013490. https:\/\/doi.org\/10.1039\/c9mt00271e","journal-title":"Metallomics"},{"key":"2938_CR25","doi-asserted-by":"publisher","first-page":"39290","DOI":"10.1038\/srep39290","volume":"6","author":"L Zheng","year":"2016","unstructured":"Zheng L, Zhu HZ, Wang BT, Zhao QH, Du XB, Zheng Y et al (2016) Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer\u2019s disease. Sci Rep 6:39290. https:\/\/doi.org\/10.1038\/srep39290","journal-title":"Sci Rep"},{"issue":"2","key":"2938_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848\u2013858. https:\/\/doi.org\/10.1038\/nprot.2006.116","journal-title":"Nat Protoc"},{"issue":"1","key":"2938_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47\u201360. https:\/\/doi.org\/10.1016\/0165-0270(84)90007-4","journal-title":"J Neurosci Methods"},{"key":"2938_CR28","doi-asserted-by":"publisher","first-page":"3974648","DOI":"10.1155\/2016\/3974648","volume":"2016","author":"N Lins","year":"2016","unstructured":"Lins N, Mour\u00e3o L, Tr\u00e9via N, Passos A, Farias JA, Assun\u00e7\u00e3o J et al (2016) Virus infections on prion diseased mice exacerbate inflammatory microglial response. Oxid Med Cell Longev 2016:3974648. https:\/\/doi.org\/10.1155\/2016\/3974648","journal-title":"Oxid Med Cell Longev"},{"issue":"7392","key":"2938_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature10907","volume":"484","author":"NC Derecki","year":"2012","unstructured":"Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG et al (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484(7392):105\u2013109. https:\/\/doi.org\/10.1038\/nature10907","journal-title":"Nature"},{"issue":"1","key":"2938_CR30","first-page":"1","volume":"19","author":"F Gallyas","year":"1971","unstructured":"Gallyas F (1971) Silver staining of Alzheimer\u2019s neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19(1):1\u20138","journal-title":"Acta Morphol Acad Sci Hung"},{"issue":"5","key":"2938_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.talanta.2005.12.031","volume":"69","author":"CE Efstathiou","year":"2006","unstructured":"Efstathiou CE (2006) Estimation of type I error probability from experimental Dixon\u2019s \u201cQ\u201d parameter on testing for outliers within small size data sets. Talanta 69(5):1068\u20131071. https:\/\/doi.org\/10.1016\/j.talanta.2005.12.031","journal-title":"Talanta"},{"issue":"11","key":"2938_CR32","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1080\/03610920802474465","volume":"38","author":"JA Villasenor Alva","year":"2009","unstructured":"Villasenor Alva JA, Estrada EG (2009) A generalization of Shapiro\u2013Wilk\u2019s test for multivariate normality. Communications in Statistics - Theory and Methods 38(11):1870\u20131883. https:\/\/doi.org\/10.1080\/03610920802474465","journal-title":"Communications in Statistics - Theory and Methods"},{"issue":"4","key":"2938_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580. https:\/\/doi.org\/10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"issue":"5","key":"2938_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol 27(5):457\u2013464. https:\/\/doi.org\/10.1002\/ana.410270502","journal-title":"Ann Neurol"},{"issue":"7","key":"2938_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13(7):812\u2013818. https:\/\/doi.org\/10.1038\/nn.2583","journal-title":"Nat Neurosci"},{"issue":"11","key":"2938_CR36","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.1074\/jbc.M310001200","volume":"279","author":"Q Li","year":"2004","unstructured":"Li Q, S\u00fcdhof TC (2004) Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279(11):10542\u201310550. https:\/\/doi.org\/10.1074\/jbc.M310001200","journal-title":"J Biol Chem"},{"issue":"6","key":"2938_CR37","doi-asserted-by":"publisher","first-page":"e21337","DOI":"10.1371\/journal.pone.0021337","volume":"6","author":"S Hogl","year":"2011","unstructured":"Hogl S, Kuhn PH, Colombo A, Lichtenthaler SF (2011) Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and \u03b3-secretase. PLoS ONE 6(6):e21337. https:\/\/doi.org\/10.1371\/journal.pone.0021337","journal-title":"PLoS ONE"},{"issue":"6","key":"2938_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00775-017-1463-2","volume":"22","author":"Y Xie","year":"2017","unstructured":"Xie Y, Tan Y, Zheng Y, Du X, Liu Q (2017) Ebselen ameliorates beta-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer\u2019s disease mice. J Biol Inorg Chem 22(6):851\u2013865. https:\/\/doi.org\/10.1007\/s00775-017-1463-2","journal-title":"J Biol Inorg Chem"},{"key":"2938_CR39","doi-asserted-by":"publisher","first-page":"145345","DOI":"10.1155\/2013\/145345","volume":"2013","author":"XY Choo","year":"2013","unstructured":"Choo XY, Alukaidey L, White AR, Grubman A (2013) Neuroinflammation and copper in Alzheimer\u2019s disease. Int J Alzheimers Dis 2013:145345. https:\/\/doi.org\/10.1155\/2013\/145345","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"2938_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neulet.2012.04.030","volume":"518","author":"X Mao","year":"2012","unstructured":"Mao X, Ye J, Zhou S, Pi R, Dou J, Zang L et al (2012) The effects of chronic copper exposure on the amyloid protein metabolisim associated genes\u2019 expression in chronic cerebral hypoperfused rats. Neurosci Lett 518(1):14\u201318. https:\/\/doi.org\/10.1016\/j.neulet.2012.04.030","journal-title":"Neurosci Lett"},{"key":"2938_CR41","doi-asserted-by":"publisher","first-page":"623241","DOI":"10.1155\/2013\/623241","volume":"2013","author":"A Rembach","year":"2013","unstructured":"Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C et al (2013) Decreased copper in Alzheimer\u2019s disease brain is predominantly in the soluble extractable fraction. Int J Alzheimers Dis 2013:623241. https:\/\/doi.org\/10.1155\/2013\/623241","journal-title":"Int J Alzheimers Dis"},{"key":"2938_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-319-60189-2_10","volume":"18","author":"ZK Mathys","year":"2017","unstructured":"Mathys ZK, White AR (2017) Copper and Alzheimer\u2019s Disease Adv Neurobiol 18:199\u2013216. https:\/\/doi.org\/10.1007\/978-3-319-60189-2_10","journal-title":"Copper and Alzheimer's Disease Adv Neurobiol"},{"issue":"Suppl 1","key":"2938_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics. J Neurochem 139(Suppl 1):179\u2013197. https:\/\/doi.org\/10.1111\/jnc.13425","journal-title":"J Neurochem"},{"issue":"8","key":"2938_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1515\/revneuro-2017-0006","volume":"28","author":"S Kozlov","year":"2017","unstructured":"Kozlov S, Afonin A, Evsyukov I, Bondarenko A (2017) Alzheimer\u2019s disease: as it was in the beginning. Rev Neurosci 28(8):825\u2013843. https:\/\/doi.org\/10.1515\/revneuro-2017-0006","journal-title":"Rev Neurosci"},{"issue":"10","key":"2938_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.chembiol.2017.07.014","volume":"24","author":"ND Telling","year":"2017","unstructured":"Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ et al (2017) Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease. Cell Chem Biol 24(10):1205-1215.e1203. https:\/\/doi.org\/10.1016\/j.chembiol.2017.07.014","journal-title":"Cell Chem Biol"},{"issue":"6","key":"2938_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde.\u201d Clin Anat 8(6):429\u2013431. https:\/\/doi.org\/10.1002\/ca.980080612","journal-title":"Clin Anat"},{"issue":"3","key":"2938_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1248\/yakushi.128.413","volume":"128","author":"N Shioda","year":"2008","unstructured":"Shioda N, Morioka M, Fukunaga K (2008) Vanadium compounds enhance adult neurogenesis after brain ischemia. Yakugaku Zasshi 128(3):413\u2013417. https:\/\/doi.org\/10.1248\/yakushi.128.413","journal-title":"Yakugaku Zasshi"},{"key":"2938_CR48","doi-asserted-by":"crossref","unstructured":"Luchsinger JA (2012) Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 30 Suppl 2(0):S185\u2013198","DOI":"10.3233\/JAD-2012-111433"},{"issue":"5","key":"2938_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61(5):661\u2013666. https:\/\/doi.org\/10.1001\/archneur.61.5.661","journal-title":"Arch Neurol"},{"issue":"6","key":"2938_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2337\/diacare.24.6.1060","volume":"24","author":"F Grodstein","year":"2001","unstructured":"Grodstein F, Chen J, Wilson RS, Manson JE (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24(6):1060\u20131065. https:\/\/doi.org\/10.2337\/diacare.24.6.1060","journal-title":"Diabetes Care"},{"issue":"10","key":"2938_CR51","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/bf02658517","volume":"39","author":"F Lithner","year":"1996","unstructured":"Lithner F (1996) Diabetes mellitus and Alzheimer\u2019s disease. Diabetologia 39(10):1242. https:\/\/doi.org\/10.1007\/bf02658517","journal-title":"Diabetologia"},{"issue":"2","key":"2938_CR52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N et al (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39(2):300\u2013307. https:\/\/doi.org\/10.2337\/dc15-1588","journal-title":"Diabetes Care"},{"issue":"6","key":"2938_CR53","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"FG De Felice","year":"2009","unstructured":"De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP et al (2009) Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A 106(6):1971\u20131976. https:\/\/doi.org\/10.1073\/pnas.0809158106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2938_CR54","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00001756-200404290-00005","volume":"15","author":"A Rickle","year":"2004","unstructured":"Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF (2004) Akt activity in Alzheimer\u2019s disease and other neurodegenerative disorders. NeuroReport 15(6):955\u2013959. https:\/\/doi.org\/10.1097\/00001756-200404290-00005","journal-title":"NeuroReport"},{"issue":"1","key":"2938_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","volume":"93","author":"RJ Griffin","year":"2005","unstructured":"Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P et al (2005) Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology. J Neurochem 93(1):105\u2013117. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02949.x","journal-title":"J Neurochem"},{"issue":"4","key":"2938_CR56","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinorgbio.2008.12.003","volume":"103","author":"KH Thompson","year":"2009","unstructured":"Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C (2009) Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 103(4):554\u2013558. https:\/\/doi.org\/10.1016\/j.jinorgbio.2008.12.003","journal-title":"J Inorg Biochem"},{"issue":"3","key":"2938_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0002-9440(10)65184-x","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol 155(3):853\u2013862. https:\/\/doi.org\/10.1016\/s0002-9440(10)65184-x","journal-title":"Am J Pathol"},{"issue":"53","key":"2938_CR58","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/jneurosci.2692-08.2008","volume":"28","author":"D Puzzo","year":"2008","unstructured":"Puzzo D, Privitera L, Leznik E, F\u00e0 M, Staniszewski A, Palmeri A et al (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28(53):14537\u201314545. https:\/\/doi.org\/10.1523\/jneurosci.2692-08.2008","journal-title":"J Neurosci"},{"issue":"5","key":"2938_CR59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaneurol.2013.48","volume":"70","author":"M Handoko","year":"2013","unstructured":"Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K et al (2013) Correlation of specific amyloid-\u03b2 oligomers with tau in cerebrospinal fluid from cognitively normal older adults. JAMA Neurol 70(5):594\u2013599. https:\/\/doi.org\/10.1001\/jamaneurol.2013.48","journal-title":"JAMA Neurol"},{"issue":"5","key":"2938_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/NEN.0b013e318217a118","volume":"70","author":"B DaRocha-Souto","year":"2011","unstructured":"DaRocha-Souto B, Scotton TC, Coma M, Serrano-Pozo A, Hashimoto T, Seren\u00f3 L et al (2011) Brain oligomeric \u03b2-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein\/tau transgenic mice. J Neuropathol Exp Neurol 70(5):360\u2013376. https:\/\/doi.org\/10.1097\/NEN.0b013e318217a118","journal-title":"J Neuropathol Exp Neurol"},{"key":"2938_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2016.11.006","volume":"793","author":"G Cao","year":"2016","unstructured":"Cao G, Su P, Zhang S, Guo L, Zhang H, Liang Y et al (2016) Ginsenoside Re reduces A\u03b2 production by activating PPAR\u03b3 to inhibit BACE1 in N2a\/APP695 cells. Eur J Pharmacol 793:101\u2013108. https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.006","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2938_CR62","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46(6):860\u2013866. https:\/\/doi.org\/10.1002\/1531-8249(199912)46:6%3c860::aid-ana8%3e3.0.co;2-m","journal-title":"Ann Neurol"},{"issue":"1","key":"2938_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0022-510x(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 158(1):47\u201352. https:\/\/doi.org\/10.1016\/s0022-510x(98)00092-6","journal-title":"J Neurol Sci"},{"issue":"11","key":"2938_CR64","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.1074\/jbc.M110.177246","volume":"286","author":"WT Chen","year":"2011","unstructured":"Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR (2011) Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation. J Biol Chem 286(11):9646\u20139656. https:\/\/doi.org\/10.1074\/jbc.M110.177246","journal-title":"J Biol Chem"},{"issue":"12","key":"2938_CR65","doi-asserted-by":"publisher","first-page":"e1800107","DOI":"10.1002\/mnfr.201800107","volume":"62","author":"Y Xie","year":"2018","unstructured":"Xie Y, Liu Q, Zheng L, Wang B, Qu X, Ni J et al (2018) Se-methylselenocysteine ameliorates neuropathology and cognitive deficits by attenuating oxidative stress and metal dyshomeostasis in Alzheimer model mice. Mol Nutr Food Res 62(12):e1800107. https:\/\/doi.org\/10.1002\/mnfr.201800107","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"2938_CR66","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neurobiolaging.2014.07.035","volume":"36","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang R, Gu J, Yin X, Jin N, Xie S et al (2015) Cross talk between PI3K-AKT-GSK-3beta and PP2A pathways determines tau hyperphosphorylation. Neurobiol Aging 36(1):188\u2013200. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.035","journal-title":"Neurobiol Aging"},{"key":"2938_CR67","doi-asserted-by":"publisher","unstructured":"Li G-P, Jiang L, Ni J-Z, Liu Q, Zhang Y (2014) Computational identification of a new SelD-like family that may participate in sulfur metabolism in hyperthermophilic sulfur-reducing archaea. Bmc Genomics 15 https:\/\/doi.org\/10.1186\/1471-2164-15-908","DOI":"10.1186\/1471-2164-15-908"},{"issue":"1","key":"2938_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0006-8993(02)03893-3","volume":"961","author":"RW Shin","year":"2003","unstructured":"Shin RW, Kruck TP, Murayama H, Kitamoto T (2003) A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer\u2019s disease. Brain Res 961(1):139\u2013146. https:\/\/doi.org\/10.1016\/s0006-8993(02)03893-3","journal-title":"Brain Res"},{"issue":"3","key":"2938_CR69","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2174\/1567205011310030011","volume":"10","author":"S Sivanesan","year":"2013","unstructured":"Sivanesan S, Tan A, Rajadas J (2013) Pathogenesis of Abeta oligomers in synaptic failure. Curr Alzheimer Res 10(3):316\u2013323. https:\/\/doi.org\/10.2174\/1567205011310030011","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"2938_CR70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuroscience.2007.11.011","volume":"151","author":"F Han","year":"2008","unstructured":"Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K (2008) The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice. Neuroscience 151(3):671\u2013679. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.11.011","journal-title":"Neuroscience"},{"issue":"3","key":"2938_CR71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0197-4580(95)00035-d","volume":"16","author":"LM Callahan","year":"1995","unstructured":"Callahan LM, Coleman PD (1995) Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer\u2019s disease. Neurobiol Aging 16(3):311\u2013314. https:\/\/doi.org\/10.1016\/0197-4580(95)00035-d","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2938_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0166-4328(95)00214-6","volume":"78","author":"IA Cook","year":"1996","unstructured":"Cook IA, Leuchter AF (1996) Synaptic dysfunction in Alzheimer\u2019s disease: clinical assessment using quantitative EEG. Behav Brain Res 78(1):15\u201323. https:\/\/doi.org\/10.1016\/0166-4328(95)00214-6","journal-title":"Behav Brain Res"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-021-02938-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-021-02938-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-021-02938-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:22:18Z","timestamp":1655346138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-021-02938-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2938"],"URL":"https:\/\/doi.org\/10.1007\/s12011-021-02938-1","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed in compliance with the institutional guidelines at Shenzhen University. The protocol was approved by the Laboratory Animal Ethics Committee of Shenzhen University (Permit Number: AEWC-20140615\u2013002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the authors participated as at appropriate to the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All other authors have read the manuscript and have agreed to submit it in its current form for consideration for publication in the Biological Trace Element Research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}